Researchers found differences in how the regions work together during certain tasks, which may help clinicians treat and assess OCD more effectively.

Yu-Wen Alvin Huang and Ryan O'Rourke's Acre Therapeutics is a winner of the the 2025 NIA Start-Up Challenge, and was awarded $65,000 by the National Institute on Aging.

Mohamed Sherif's upcoming clinical trial of psychedelics to treat OCD is spotlighted in this Guardian article.

Alice Lin, Vanessa Rivera Núñez, Alisa Salazar, Lewis Núñez Severino and Zachary Uttke presented on findings that will advance research into Alzheimer's disease, developmental disorders, an epilepsy syndrome, obsessive compulsive disorder and post-traumatic stress disorder.

Carney new hire Leenoy Meshulam is June and Howard Zimmerman Assistant Professor of Physics, Neuroscience, and Brain Science.

The gene PDZD8 speeds up cellular recycling, enabling neurons to make synapses during early development, researchers in the O’Connor-Giles lab found.

Carney-affiliated Professor of Neuroscience Stephanie Jones was honored by NINDS for distinguished interdisciplinary mentorship.

The ability to gossip effectively and with such precision is a testament to the mind’s sophistication—a feature, not a bug.

Krishna Amin, Sicheng Liu, Caroline McLaughlin, Noe Mercado, Rareș Moșneanu and Diana Wall are working to help treat serious brain conditions and to develop groundbreaking tools to advance neuroscience research.

Our genomes are peppered with DNA segments called retrotransposons that can move from place to place. When unleashed, some can kill nerves and promote inflammation — a discovery that may inspire treatments for neurodegeneration.